InflectraTM, Europe's first biosimilar monoclonal antibody therapy that has been approved for the treatment of inflammatory conditions including rheumatoid arthritis , ankylosing spondylitis, Crohn's disease , ulcerative colitis , psoriatic arthritis and psoriasis.
More...
More...